 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Summaries
Boundless Bio
BOLD
conference date: to be announced. I am adding to my coverage list starting with Q2 2025.
| 2025 | |||
| TBA | |||
| Q2 2025 | |||
Boundless Bio (BOLD) is a clinical-stage biotechnology company specializing in cancer therapies
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALNY |
| AMAT |
| AMGN |
| APRE |
| ARWR |
| BIIB |
| BMY |
| CLDX |
| CDTX |
| GILD |
| ILMN |
| IMGN |
| INCY |
| INKT |
| INO |
| IONS |
| MCHP |
| MRNA |
| PLX |
| REGN |
| RNA |
| RXRX |
| SAGE |
| SANA |
| VRTX |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2025 William P. Meyers